Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Agile Therapeutics Recent news which mentions Agile Therapeutics Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024 November 21, 2023 Tickers AGRX Tags General Market News Partner Content From Benzinga Agile Therapeutics (NASDAQ: AGRX) Upgraded To "Buy" Rating By Analysts At Maxim Group September 27, 2023 Tickers AGRX Tags General Partner Content Markets From Benzinga Agile Says It's On Track To Hit $25-$30 Million Net Annual Revenue After A Strong Performance In Its Second Quarter August 16, 2023 Tickers AGRX Tags AGRX Agile Therapeutics Penny Stocks From Benzinga This Reproductive Health Company's Weekly Contraceptive Patch Can Reach Millions Of Women Thanks To A Partnership With Afaxys July 17, 2023 Tickers AGRX Tags Market News Afaxys Pharma Partner Content From Benzinga Agile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Women July 14, 2023 Tickers AGRX Tags General Market News Partner Content From Benzinga Agile Sees Renewed Hope For Even Broader Adoption Of Its Weekly Birth Control Patch After Biden's Latest Executive Order Expanding Contraceptive Coverage July 10, 2023 Tickers AGRX Tags Penny Stocks Benzinga Agile Therapeutics From Benzinga H.C. Wainwright Reiterates Buy Rating For Agile Therapeutics (NASDAQ: AGRX), Citing Growing Demand For Twirla, A Weekly Low Dose Birth Control Patch June 29, 2023 Tickers AGRX Tags Partner Content General Benzinga From Benzinga This Women's Healthcare Company Raised $7.5 Million In A Public Offering And Says It's Targeting $25 To $30 Million Net Revenue By End Of 2023 June 26, 2023 Tickers AGRX Tags AGRX Agile Therapeutics Penny Stocks From Benzinga Agile Therapeutics – This Women's Healthcare Company's "Skinfusion" Technology Sets It Apart From Other Contraceptive Companies June 16, 2023 Tickers AGRX Tags General Market News Markets From Benzinga Agile Therapeutics Expects Its Innovative Once-A-Week Birth Control Patch To Drive Revenues Of $25-30 Million In 2023 – What Is The Hype All About? June 05, 2023 Tickers AGRX Tags Benzinga Penny Stocks Agile Therapeutics From Benzinga The Overturning of Roe v. Wade Has Changed The Landscape Of Birth Control; Smaller Companies Are Now An Integral Part Of Care June 01, 2023 Tickers AGRX Tags Partner Content Market News General From Benzinga Agile Therapeutics: The CEO Of This Women's Healthcare Company That Recently Saw Revenue Growth Of 33% Speaks To Benzinga May 03, 2023 Tickers AGRX Tags Agile Therapeutics AGRX Health Care From Benzinga Agile Therapeutics: This BioPharma Firm Is Nimbly Solving Unmet Needs For Women January 19, 2023 Tickers AGRX Tags Interview Benzinga Penny Stocks From Benzinga This Biotech Company is Pursuing Positive Cash Flow In 2023 December 20, 2022 Tickers AGRX CVS Tags AGRX Agile Therapeutics Biotech From Benzinga Women's Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow November 14, 2022 Tickers AGRX DARE HOLX Tags Agile Therapeutics HOLX AGRX From Benzinga Can This Company's Birth Control Patch Disrupt The Contraceptive Market? October 25, 2022 Tickers AGRX DARE Tags Health Care Benzinga Penny Stocks From Benzinga The Past Week's Notable Insider Buys Included Digitalbridge, Life Time, A SPAC And More October 16, 2021 Tickers AGRX DBRG LOKB LTH Tags AGRX Benzinga Life Time From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
